Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00618904 · ClinicalTrials.gov registry record · NA

Efficacy of Probiotic Bacteria in Subjects With IBS or Functional Diarrhea/ Bloating

A NA study of Pain, sponsored by University of North Carolina, Chapel Hill.

Completed
Registry status
NA
Development phase
56
Enrollment target
1
Study location

NCT00618904 is a NA study of Pain that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 56 participants, below the 304-participant average among 374 other Pain trials with a reported enrollment target (82% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00618904, a NA study of Pain, has completed, sponsored by University of North Carolina, Chapel Hill.

COMPLETED
Registry status
NA
Development phase
56 participants
Enrollment target
1
Study location

Study Summary

To determine if probiotics bacteria, specifically lactobacillus and bifidobacterium, improve gastrointestinal symptoms in patients with IBS, functional diarrhea, or functional bloating.

Conditions Studied

Interventions

  • DIETARY_SUPPLEMENT Placebo
  • DIETARY_SUPPLEMENT Probiotics - Lactobacillus and bifidobacterium

Study Locations (1)

North Carolina

  • University of North Carolina at Chapel Hill - Chapel Hill

Trial Details

FieldValue
Enrollment Target 56 participants
Start Date 2005-12
Est. Completion 2007-09
Phase NA

What the Registry Record Tells You About NCT00618904

The ClinicalTrials.gov registry entry for NCT00618904 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 56 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 304-participant average among 374 other Pain trials with a reported enrollment target (82% lower). The listed sponsor is University of North Carolina, Chapel Hill, which has 1,109 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Pain appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT00618904 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.

Frequently Asked Questions

What is clinical trial NCT00618904 about?

NCT00618904 is a clinical study titled "Efficacy of Probiotic Bacteria in Subjects With IBS or Functional Diarrhea/ Bloating". To determine if probiotics bacteria, specifically lactobacillus and bifidobacterium, improve gastrointestinal symptoms in patients with IBS, functional diarrhea, or functional bloating.

What is the current status of trial NCT00618904?

This trial is currently completed. It is a NA study. The enrollment target is 56 participants. The study started on 2005-12. Estimated completion is 2007-09.

What conditions does trial NCT00618904 study?

This clinical trial studies the following conditions: Pain.

What interventions are being tested in trial NCT00618904?

The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Probiotics - Lactobacillus and bifidobacterium (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT00618904?

This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00618904 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.